Eli Lilly and Company -- Physician Payments Report
This page provides a comprehensive analysis of Eli Lilly and Company's payments to physicians, as reported in the CMS Open Payments (Sunshine Act) database. DoctorPharmaData enhances this data with AI-powered analysis to help patients understand pharmaceutical company spending patterns.
Spending Summary
Eli Lilly and Company has made $6,651,113.83 in total payments to 0 physicians across 816 recorded transactions.
- Total Physician Spending: $6,651,113.83
- Total Physicians Paid: 0
- Total Payment Transactions: 816
Recent Payment Records
The following table shows the most recent payments from Eli Lilly and Company to physicians as recorded in the CMS Open Payments database.
| Doctor | Specialty | Amount | Type | Date |
|---|---|---|---|---|
| Emily Thompson | Neurology | $20,804.72 | consulting | 2026-04-06 |
| Rachel Parker | Rheumatology | $7,832.99 | consulting | 2026-04-02 |
| Patricia Davis | Neurology | $1,314.02 | general | 2026-04-01 |
| Kevin Hill | Endocrinology | $1,535.53 | travel | 2026-04-01 |
| Daniel White | Rheumatology | $139.82 | meals | 2026-03-31 |
| Daniel White | Neurology | $9,504.07 | research | 2026-03-30 |
| Matthew Walker | Rheumatology | $16,978.67 | consulting | 2026-03-30 |
| Laura Hall | Endocrinology | $117.92 | meals | 2026-03-30 |
| Charles Baker | Oncology | $427.16 | general | 2026-03-29 |
| William Lee | Psychiatry | $411.05 | travel | 2026-03-29 |
| Angela Stewart | Oncology | $180.53 | meals | 2026-03-29 |
| Eric Sanchez | Oncology | $13,975.94 | speaking | 2026-03-28 |
| Maria Martinez | Psychiatry | $16,963.12 | consulting | 2026-03-28 |
| Eric Sanchez | Neurology | $90.50 | meals | 2026-03-27 |
| Scott Collins | Psychiatry | $168.13 | meals | 2026-03-27 |
Understanding Pharmaceutical Company Payment Reports
Under the Physician Payments Sunshine Act, pharmaceutical and medical device companies must report all payments and transfers of value to licensed physicians and teaching hospitals. Eli Lilly and Company is required to disclose every payment, including consulting fees, speaking engagements, meals, travel, research funding, and ownership interests.
A high spending total does not necessarily indicate improper behavior. Large pharmaceutical companies with extensive product portfolios naturally make more payments to physicians. However, examining the patterns of spending -- which specialties are targeted, which doctors receive the most, and what types of payments predominate -- can provide valuable insights for patients.
Related Resources
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice.